Organigram Global Expands FAST(TM) Innovation Platform with SHRED Shotz, Leveraging SHRED Brand Equity

Executive Summary

• Organigram Global Inc. announced the launch of SHRED Shotz, a 65 ml single‑serve cannabis beverage powered by its FAST™ nanoemulsion technology, delivering a rapid 15‑minute onset.
• Each bottle contains 10 mg THC and will be available in two flavours (Blue Razzberry and OG Lemonade) beginning March 2026 in Ontario and Atlantic Canada, with rollout to other provinces thereafter.
• The launch leverages the SHRED brand’s $200 M retail sales momentum and showcases Organigram’s FAST™ platform, which has demonstrated up‑to‑50 % faster onset and increased bioavailability versus traditional ingestibles.

Key Details

• Product: SHRED Shotz – 65 ml cannabis beverage (single‑serve).
• Technology: FAST™ nanoemulsion platform (patent‑pending) designed for fast‑acting, consistent performance; prior PK studies show ~50 % faster onset and up to double cannabinoid delivery at peak.
• THC Content: 10 mg per bottle.
• Flavours: Blue Razzberry and OG Lemonade.
• Launch Timing: Expected availability in Canadian cannabis retailers March 2026 (initially Ontario & Atlantic Canada; expansion to other provinces soon after).
• Brand Context: SHRED brand achieved >$200 M retail sales in 2025, underscoring strong market traction and supporting the new format extension.
• Executive Quote: Eric Williams, VP of Marketing – “SHRED Shotz is another clear example of how we successfully translate consumer insights into meaningful product innovation… expanding into new occasions with a format built for taste, convenience and predictability.”
• Strategic Rationale: Extends Organigram’s differentiated innovation pipeline, broadens the cannabis beverage category, and aims to attract new consumers through a convenient, fast‑onset format.

Notable Quotes

“SHRED Shotz is another clear example of how we successfully translate consumer insights into meaningful product innovation,” said Eric Williams, Organigram Global’s Vice President of Marketing.

All forward‑looking statements are subject to risks and uncertainties detailed in the company’s filings.